1. Home
  2. BDSX vs HEQ Comparison

BDSX vs HEQ Comparison

Compare BDSX & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$13.29

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Hedged Equity & Income Fund of Beneficial Interest

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$11.34

Market Cap

130.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
HEQ
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
130.0M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
BDSX
HEQ
Price
$13.29
$11.34
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
55.4K
46.0K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$9.73
52 Week High
$20.21
$11.58

Technical Indicators

Market Signals
Indicator
BDSX
HEQ
Relative Strength Index (RSI) 43.74 59.92
Support Level $6.00 $10.55
Resistance Level $16.26 $11.58
Average True Range (ATR) 1.04 0.22
MACD -0.22 0.07
Stochastic Oscillator 26.76 87.10

Price Performance

Historical Comparison
BDSX
HEQ

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return, with a focus on current income and gains, and to include long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: